Ivabradine Impurity 39
 
		Product Description
CAT No.
				
									ALN-I014071								
				CAS No.
				
									1235547-06-4								
				Mol. F.
				
									C15H19NO4								
				Mol. Wt.
				
									277.3								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : 3-(3-Hydroxypropyl)-7,8-dimethoxy-1,3-dihydro-2H-benzo[d]azepin-2-one								
				
									Smiles : O=C1N(CCCO)C=CC2=CC(OC)=C(OC)C=C2C1								
				
									Inchi : InChI=1S/C15H17NO3/c1-4-6-16-7-5-11-8-13(18-2)14(19-3)9-12(11)10-15(16)17/h4-5,7-9H,1,6,10H2,2-3H3								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Forced Degradation Studies of Ivabradine and In Silico Toxicology Predictions for Its New Designated Impurities
									Piotr Pikul,1 Marzena Jamru00f3giewicz,1,* Joanna Nowakowska,1 Weronika Hewelt-Belka,2,3 and Krzesimir CiuranFront Pharmacol. 2016; 7: 117.								
				Simultaneous determination of chiral and achiral impurities of ivabradine on a cellulose tris(3-chloro-4-methylphenylcarbamate) chiral column using polar organic mode
									 Joanna Nowakowska,1 Weronika Hewelt-Belka,2,3 and Krzesimir Ciura – Front Pharmacol. 2016; 7: 117. 								
				Characterization of degradation products of Ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis
									ElekFerenczabBélaKovácsabFranciscBodaaMohammadhassanForoughbakhshfasaeicÉva KatalinKelemenbGerg?TóthcZoltán-IstvánSzabó – Journal of Pharmaceutical and Biomedical Analysis Volume 177, 5 January 2020, 112851 								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            